Search clinical trials for: Sebaceous Carcinoma

Total 30433 results

National Institute of Cancerología

Unknown

Hydralazine Valproate for Ovarian Cancer

Ovarian Cancer

Mexico
Introgen Therapeutics

Unknown

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Carcinoma, Squamous Cell

United States
Heidelberg University

Unknown

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer (OVAR-IMRT-01)

Ovarian Cancer

Germany
Intarcia Therapeutics

Terminated

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Breast Neoplasms | Neoplasms, Hormone-Dependent

United States, Ukraine, Canada, Russian Federation
National Cancer Institute, Naples

Completed

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Endometrial Cancer

Italy
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Oropharyngeal Neoplasms

France
Intarcia Therapeutics

Terminated

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Breast Neoplasms | Neoplasms, Hormone-Dependent

United States, Romania, Russian Federation, Ukraine, Bulgaria
MedImmune LLC

Completed

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Esophagitis | Non-Small Cell Lung Carcinoma | Pneumonitis

United States
ARCAGY/ GINECO GROUP
Hoffmann-La Roche

Terminated

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Ovarian Cancer

France
Abbott

Completed

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

United States, Netherlands
Abbott

Terminated

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company
Gynecologic Oncology Group

Completed

A Trial for Patients With Gestational Trophoblastic Disease

Uterine Neoplasms | Trophoblastic Neoplasms | Hydatidiform Mole | Choriocarcinoma

United States
University Hospital, Montpellier
University Hospital, Angers; University Hospital, Rouen; University Hospital,... and other collaborators

Terminated

Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study

Colorectal Obstruction | Left Colonic Adenocarcinoma
Adherex Technologies, Inc.

Completed

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Neoplasms

United States, Canada
Adherex Technologies, Inc.

Completed

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Neoplasms

United States
National Taiwan University Hospital
Mackay Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Completed

Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer

Gastric Cancer

Taiwan
National Taiwan University Hospital

Completed

Weekly TP-HDFL in the Treatment of Advanced TCC

Transitional Cell Carcinoma

Taiwan
National Taiwan University Hospital

Completed

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Completed

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Transitional Cell Carcinoma

Taiwan
Weill Medical College of Cornell University

Terminated

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Head and Neck Cancer

United States
McGill University Health Centre/Research Institute...

Unknown

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

Pain | Breast Cancer | Prostate Cancer | Vertebral Metastasis

Canada
Tianjin Medical University

Unknown

A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer

Breast Cancer

China
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Eli Lilly and Company

Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Slovakia
Eli Lilly and Company

Completed

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

Biliary Tract Carcinoma

Korea, Republic of
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom
Eli Lilly and Company

Completed

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

Non-Small Cell Lung Cancer

China
Eli Lilly and Company

Completed

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

Schizophrenia

China
Eli Lilly and Company

Completed

A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia

Schizophrenia

Japan
Point Therapeutics

Terminated

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, Pulmonary

United States
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Point Therapeutics

Terminated

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Adenocarcinoma | Neoplasm Metastasis | Pancreatic Cancer

United States
University of Roma La Sapienza

Completed

Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer

Endometrial Cancer
Skane University Hospital
Swedish Cancer Society; Europe Against Cancer (European Union Directorate General...

Completed

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening (SWEDESCREEN)

Cervical Cancer | Cervical Intraepithelial Neoplasia

Sweden
Shandong University

Completed

Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm (TACE-RFA)

Hepatocellular Carcinoma
University Hospital, Geneva

Unknown

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

Hepatocellular Carcinoma

Switzerland
Tampere University

Completed

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Prostate Cancer

Finland
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Novacea
Aventis Pharmaceuticals

Completed

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Pfizer

Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms

United States
Eli Lilly and Company

Completed

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

United States
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
University of Saskatchewan
Sanofi

Terminated

Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

Platinum Sensitive Relapsed Ovarian Cancer

Canada
Gunma University

Completed

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer

Carcinoma, Non-Small-Cell Lung
University of Aarhus

Unknown

MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Ovarian Cancer
University of Glasgow
NHS Greater Glasgow and Clyde; Glasgow Western Infirmary

Unknown

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

Basal Cell Carcinoma

United Kingdom
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States
University Hospital, Geneva

Unknown

Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Pancreatic Neoplasms | Cholangiocarcinoma | Pancreatitis

Argentina
Women and Infants Hospital of Rhode Island
Millennium Pharmaceuticals, Inc.

Terminated

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Cervical Cancer

United States
Grupo de Estudio de Infecciones en Transplantados
Merck Sharp & Dohme LLC

Unknown

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

Liver Transplantation | Fungal Infection

Spain

3

Subscribe